Innovative, Fundable, Early Stage Opportunities
Each company featured in the Emerging Company Showcase was nominated, reviewed and invited to present based upon their innovative science and the quality of their management team. They presented before a panel of ‘Pitch Doctors’, early stage VCs and investors, corporate VCs, strategic partners and other investors and advisors, who asked questions about their science and strategy.
2020 Showcase Sponsored By:
Presenting Companies
 |
Anschel Technology, Inc., Rocky Point, NY: Commercializing SightSaver™, an FDA approved and patented device designed to monitor visual pathways and prevent vision loss during surgery. |
 |
Aqumin LLC, Houston, TX: Developing: AlphaVision for Medical (AVM) which facilitates the seamless transition from current table-based views of data to an interactive, ‘eagle-eye’ view in a multi-dimensional workspace that enables ad-hoc pattern discovery in minutes. |
 |
Avery Therapeutics, Tucson, AZ: Developing tissue-engineered therapeutics to treat diseases and injuries to human muscle. |
 |
AxoSim, Inc. New Orleans, LA: Developing neuroscience drug discovery platform technologies including NerveSim™ and BrainSim™. |
 |
BioIncept, LLC, New York, NY: Developing therapeutics and diagnostics to transform the treatment of radiation-induced injury, and success of in-vitro fertilization. |
 |
BLR Bio, Kenosha, WI: Developing biologics and diagnostics for the treatment of Cancer and a broad spectrum of serious Fibrotic Diseases. |
 |
Brevitest Technologies, Houston, TX: developing a biomedical assay platform technology to perform ELISAs (enzyme-linked immunosorbent assays) in a microfluidic environment. |
 |
Cicero Diagnostics, Huntington Beach, CA: Developing ReceptivaDx™, to detect inflammation most often associated with asymptomatic endometriosis. |
 |
CMTx Biotech, Stony Brook, NY : Working to repurpose a clinical-stage small molecule, incyclinide, for the treatment of hospitalized COVID-19 patients. |
 |
CRYOCRATE, LLC, Columbia MO: Developing Cryopreservation solutions for cells and tissues that currently cannot be maintained under current medium and long-term storage solutions. |
 |
Cytex Therapeutics, Durham, NC: Developing tissue regeneration technology for the treatment of osteoarthritis. |
 |
Diagnologix, San Diego, CA: Developing microbubbles-enabled separation method (BUBLES: buoyancy enabled separation) and system for clinical and research applications. |
 |
EVQLV, New York, NY: Develops artificial intelligence engineered with life science data to accelerate how biologic therapies reach those in need. |
 |
Fairbanks Pharmaceuticals, Concord, MA: Developing novel diabetes therapy to address the underlying cause of the disease. |
 |
GoDx, Inc, Madison, WI: Developing a paper-based test to accurately detect the specific bugs that cause diarrheal diseases. |
 |
Goldilocks Therapeutics, Inc, New York, NY: Developing preventatives and/or treatments for acute kidney injury (AKI), polycystic kidney disease (PKD), and other under-treated kidney conditions utilizing mesoscale nanoparticles (MNPs). |
 |
Gypsy Basin Genomics, New York, NY: Developing a test for oral and cervical HPV infection that provides early detection of precancerous cellular changes. |
 |
HemoTag, Boca Raton, FL: Developed by Aventusoft, the HEMOTAG system utilizes a sensing technology known as computational auditory scene analysis to localize, separate and interpret different acoustic events in the heart. |
 |
i-Cordis, St. Louis, MO: Developing a first in class immunomodulatory molecule to prevent and treat heart failure. (NIC) |
 |
IRIA Pharma, Champaign, IL: Developing next-generation cancer targeting and drug delivery technology for cancer treatment. |
 |
JelikaLite, New York, NY: Developing a home-based therapeutic wearable, data-device feedback system for children with autism |
 |
KeViRx: Charlottesville, VA: Developing novel anti-cancer small molecules, with a lead candidate targeting ovarian cancer. |
 |
Metaclipse Therapeutics: Atlanta, GA: Developing novel personalized vaccine immunotherapies for treating cancer including triple negative metastatic breast cancer. |
 |
Mickey’s, Brooklyn, NY: Developing e-textiles that help movement disorders patients walk more efficiently. |
 |
Micronoma, San Diego, CA & New York, NY: Developing a liquid biopsy technology to detect and predict cancer by interrogating the microbial signal |
 |
Microvascular Therapeutics, LLC, Tucson, AZ: Developing next generation contrast agents for diagnostic ultrasound. |
 |
Neuvotion, Darien, CT: Developing a wearable AI-driven neurostimulation device that delivers focal electrical energy to nerve and muscle targets to promote movement recovery |
 |
Oligomerix, Inc, New York, NY: Developing a small molecule inhibitor and biomarker platform targeting Alzheimer’s Disease |
 |
OpticSurg, New York, NY: Smart-glasses-enabled Mixed Reality Enhanced Telehealth Platform to bridge the gap in expert care and preserve frontline capacity of people and supplies of Personal Protective Equipment (PPE). |
 |
Orlance, Inc., Seattle, WA: Developing rapid-response vaccine platform that is needle and pain-free. |
 |
Pacific Diabetes Technologies, Inc., Portland, OR: Developing a drug delivering glucose sensor for treating diabetes. |
 |
Pain Care Labs (MMJ Labs), Atlanta, GA: Developing a consumer pain device focused on external neuromodulation of musculoskeletal, post-operative pain and painful procedures. |
 |
Pantherics Inc., LaJolla, CA/Madison, WI: Developing small molecule therapies for the treatment of inflammatory diseases of smooth muscle. |
 |
PHD Biosciences, New York, NY: Focusing on the development of non-prescription topical products and prescription topical and systemic products for diseases with high unmet medical need. |
 |
SFC Fluidics, Fayetteville, AK: Developing a small, low cost, highly-accurate, and software-driven disposable pump for insulin to address diabetes. |
 |
Sharper Sense, New York, NY: Developing wearable neuromodulation technology that can enhance perceptual acuity and reduce the probability of tactile, visual, and auditory misperception. |
 |
Truvitech LLC, Miami, FL: developing the idTRAX platform – a technology that transforms the speed with which drug targets are identified. |
 |
ZBeats LLC, Stony Brook, NY: Developing a cloud-based platform and AI algorithms for ECG data acquisition, transmission, storage, visualization, and analysis. |
| View the 2019 showcase presenters here. |
2020 Participating Strategic Partners and Investors*:
Alexandria Venture Investments
Amana Global Partners FZ LLC
Apollo Ventures
Atlas Strategic Advisors, LLC
Bearsville Partners LLC
BioAdvance
BioLinkUp
Biomedical Advanced Research and Development Authority
Boehringer Ingelheim
Boehringer Ingelheim Venture Fund
Breakaway Global Advisors
Brevet Capital Management
Bruder Consulting & Venture Group
Courage Growth Partners
CTI Life Sciences
Daiichi Sankyo Group
Deerfield
FC Capital Management
First Republic Bank
FoxHill Asset Management
Greenfield BioVentures
GSK
H.I.G. BioHealth Partners
Hercules Technology Capital
HitKit/Viral Forecast
IndieBio New York
IVMatters
Johnson & Johnson Innovation
Lonza
Merck
Mid Atlantic Bio Angels
Mitsui Global Investment
MPM Capital
MrBiobucks Consulting
Network 1 Financial Securities, Inc.
NSIP LLC
NYU Innovation Venture Fund
Omega Funds
ONIX HUB & VENTURES
OrbiMed Advisors LLC
Paladin Capital Group
Pappas Capital
Pathway Bioventures
Pfizer
Pfizer Ventures
Regeneron Pharmaceuticals, Inc.
Rising Dragon Associates
SVB Capital
Tectonic Capital
The Berkner Group
Vista Capital
Xontogeny, LLC
*List is for informational purposes only and subject to change without notice